These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2919107)

  • 1. Opposing effect of apomorphine on antinociceptive activity of morphine: a dose-dependent phenomenon.
    Gupta YK; Chugh A; Seth SD
    Pain; 1989 Feb; 36(2):263-269. PubMed ID: 2919107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing influences of D-1 and D-2 dopamine receptors activation on morphine-induced antinociception.
    Zarrindast MR; Moghaddampour E
    Arch Int Pharmacodyn Ther; 1989; 300():37-50. PubMed ID: 2619426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat.
    Barasi S; Duggal KN
    Eur J Pharmacol; 1985 Nov; 117(3):287-94. PubMed ID: 3841070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats.
    Jensen TS; Yaksh TL
    Brain Res; 1984 Apr; 296(2):285-93. PubMed ID: 6322926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of dopamine agonists and antagonists of baclofen antinociception in mice.
    Zarrindast MR; Moghaddampour E
    Arch Int Pharmacodyn Ther; 1991; 309():42-50. PubMed ID: 1679622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic involvement in adenosine A1 receptor-mediated antinociception in the tail flick latency model in mice.
    Malhotra J; Chaudhary G; Gupta YK
    Methods Find Exp Clin Pharmacol; 2000; 22(1):37-41. PubMed ID: 10791293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.
    Schoo SM; Bobeck EN; Morgan MM
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine may mimic the apomorphine cue by inhibiting dopaminergic autoinhibition.
    Hernandez LL; Holohean AM; Appel JB
    Eur J Pharmacol; 1982 Mar; 78(3):287-94. PubMed ID: 7067729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A; Kehr W; Lindqvist M
    J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioids and ATP-sensitive potassium channels are involved in the mediation of apomorphine-induced antinociception at the spinal level: a behavioral study in rats.
    Kang YM; Hu WM; Qiao JT
    Brain Res Bull; 1998 Jun; 46(3):225-8. PubMed ID: 9667815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of quipazine, fenfluramine and apomorphine on the morphine potentiation of tonic immobility.
    Wallnau LB
    Pharmacol Biochem Behav; 1981 Dec; 15(6):895-901. PubMed ID: 7323114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists.
    Pelissier T; Laurido C; Hernandez A; Constandil L; Eschalier A
    Eur J Pharmacol; 2006 Sep; 546(1-3):40-7. PubMed ID: 16905131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.
    Suh HW; Song DK; Choi SR; Chung KM; Kim YH
    Neuropeptides; 1996 Oct; 30(5):479-84. PubMed ID: 8923511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
    Tulunay FC; Sparber SB; Takemori AE
    Eur J Pharmacol; 1975 Aug; 33(1):65-70. PubMed ID: 1175692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of apomorphine on spinal reflex activity following 6-hydroxydopamine or long-term haloperidol pretreatment.
    Jensen TS; Christensen NJ; Smith DF
    J Neural Transm; 1986; 65(2):125-34. PubMed ID: 3084706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 receptors and spinal cord excitation in mice.
    Hasegawa Y; Kurachi M; Otomo S
    Eur J Pharmacol; 1990 Aug; 184(2-3):207-12. PubMed ID: 2150374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.